← Back to Startups

Mentari Therapeutics

Mentari Therapeutics develops targeted biologics for migraine.

Industry
Bio + Health
Tracked VC backers
1
Visit mentaritx.com ↗
View in My Fund →

RiseFinder summary

Mentari Therapeutics develops targeted biologics for migraine. Its research programs include an antibody targeting the PACAP pathway and a bispecific antibody designed to block both CGRP and PACAP.

Source category

Bio + Health

Category source ↗

Checked

Limited coverage
Tracking coverage and points

Tracking coverage

Some source history is available; coverage remains limited.

Momentum +1 · Limited coverage
The latest public index does not report a rank for this company.Index checked:
Fundraising +2 · Awaiting data
No verified dated source evidence recorded.
New VC +3 · Awaiting data
No verified dated source evidence recorded.
Completed exit +10 · Awaiting data
Exit news coverage has not started.

Coverage describes public evidence. Points require a qualifying milestone after your pick.

Publicly documented VC backing

These sources establish that the firm lists the company. The observation date records when RiseFinder captured the relationship; it does not establish when the investment happened.

Dated public activity

No dated funding or investment events are recorded yet. Initial portfolio listings establish the starting baseline and earn no points.